000 | 01097 a2200349 4500 | ||
---|---|---|---|
005 | 20250511182152.0 | ||
264 | 0 | _c19921001 | |
008 | 199210s 0 0 eng d | ||
022 | _a0048-5764 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBorison, R L | |
245 | 0 | 0 |
_aRisperidone: clinical safety and efficacy in schizophrenia. _h[electronic resource] |
260 |
_bPsychopharmacology bulletin _c1992 |
||
300 |
_a213-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoxazoles _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPiperidines _xadverse effects |
650 | 0 | 4 | _aRisperidone |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 | _aSchizophrenic Psychology |
700 | 1 | _aPathiraja, A P | |
700 | 1 | _aDiamond, B I | |
700 | 1 | _aMeibach, R C | |
773 | 0 |
_tPsychopharmacology bulletin _gvol. 28 _gno. 2 _gp. 213-8 |
|
999 |
_c1387595 _d1387595 |